2013-01-02 22:30:50 -

MENLO PARK, Calif., January 2, 2013 - Geron Corporation (Nasdaq: GERN) today
announced that John A. Scarlett, M.D., President and Chief Executive Officer,
will present an overview of the company at 1:00 p.m. Pacific Time on Thursday,
January 10, at the 31st Annual J.P. Morgan Healthcare Conference in San
Francisco.

A live webcast of the audio and slide presentation, including Q&A session, will
be available at
 jpmorgan.metameetings.com/webcasts/healthcare13/directlink?ticke ...
Following the live presentation, the webcast will be archived and available for
replay at the same address for a period of 30 days.

About Geron

Geron is a biopharmaceutical company developing first-in-class therapies for
cancer, including its telomerase inhibitor, imetelstat. For more information
about Geron, visit www.geron.com.

CONTACT:

Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com  

                                      ###



This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: Geron Corp. via Thomson Reuters ONE
[HUG#1667881]